Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Antibiotic Allergy: Phenotypes, Endotypes, and Mechanisms

Award Number: UG3AI190113
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/03/2025
PERIOD OF PERFORMANCE END DATE: 09/12/2025

Group Awards By:

View Award Description

Antibiotic Allergy: Phenotypes, Endotypes, and Mechanisms - PROJECT SUMMARY Drug allergy is the leading cause of fatal anaphylaxis in the US, with antibiotics being the most common cause of allergic reactions. For immediate penicillin allergy, evidence supports specific antigenic determinants and an immunoglobulin (lg)E-mediated mechanism. For other antibiotics, the antigenic determinants and mechanisms are not known. For some antibiotic classes, such as cephalosporins and sulfonamides, positive skin testing with non irritant concentrations supports an lgE mechanism, but for other antibiotics, such as vancomycin and fluoroquinolones, current data suggest immediate hypersensitivity reactions occur through primarily non-lgEmediated processes. Currently available tests and biomarkers for antibiotic allergy have limited utility. While fatal anaphylaxis has been associated with intravenous administration, the mechanisms supporting these observations have not yet been defined as large database studies lack accurate reaction phenotyping and structured causality assessments. Although both lgE and lgG antibodies are likely to be involved in immediate-onset allergic reactions to antibiotics, biological pathways need defining in advance of biomarker discovery given the complexity of antibiotic structures, potential epitopes, and protein and cellular interactions. In this UG3/UH3 application, we apply clinical epidemiology and translational immunology methods to enhance knowledge of immediate antibiotic allergy through extending the work of an established multi-site network of drug allergy specialists, the United States Drug Allergy Registry (USDAR) Consortium. USDAR studies include a multi-site database of participants evaluated for drug allergy (n=2,432) and a biorepository from specialistconfirmed antibiotic-allergic patients (n=28). Our overall goal is to determine the phenotypes, endotypes, and mechanisms of antibiotic allergy, including investigation of mechanistic differences according to drug route through these specific aims: 1) To describe the phenotypes and endotypes of immediate-onset allergic reactions to antibiotics, and 2) To define how delivery route impacts antibiotic anaphylaxis. We will achieve these aims through leveraging USDAR's existing research infrastructure and participants and leadership by two allergist/immunologist physician scientists with complementary methodologic expertise. This project aligns with NIH/NIAID goals to advance drug allergy research and RFA-Al-24-002 to support research that enhances understanding of the mechanisms and management of antibiotic drug allergy.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	MAYO CLINIC JACKSONVILLE (A NONPROFIT CORPORATION)	4500 SAN PABLO RD S	JACKSONVILLE	FL	32224	DUVAL	USA	Allergy and Infectious Diseases Research	001	2	1/29/2026	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$351,394
2026	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Allergy and Infectious Diseases Research	000	1	1/29/2026	NEW	-$351,394
2026	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Allergy and Infectious Diseases Research	002	1	3/26/2026	NEW	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $427,671 )
2025	2025	THE GENERAL HOSPITAL CORPORATION	55 FRUIT ST	BOSTON	MA	02114	SUFFOLK	USA	Allergy and Infectious Diseases Research	000	1	7/3/2025	NEW	$427,671
														Subtotal = $427,671

Grand Total All Awards = $427,671

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Antibiotic Allergy: Phenotypes, Endotypes, and Mechanisms

Award Number: UG3AI190113

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/03/2025

PERIOD OF PERFORMANCE END DATE: 09/12/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer